Toward a Template for Synthetic Actin-Targeting Macrolide Analogues That Inhibit Cancer Cell Invasiveness.

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Actin barbed end-binding macrolides show promise in inhibiting cancer cell motility and extracellular matrix (ECM) invasion, suggesting therapeutic potential for metastatic cancers.
• Clinical application of these macrolides is limited by low natural abundance, complex synthesis, and adverse effects on healthy tissues.

Purpose of the Study:

• To design and synthesize simpler analogues of the macrolide Mycalolide B's acyclic side chain (tail).
• To investigate the structure-activity relationship of the tail in inhibiting actin polymerization and cancer cell invasion.
• To identify analogues suitable for cell-specific targeting systems like antibodies.

Main Methods:

• Over 20 analogues of the Mycalolide B tail were synthesized.
• The analogues were tested for their ability to inhibit actin polymerization.
• The effect of analogues on extracellular matrix (ECM) invasion by human lung cancer A549 cells was evaluated.

Main Results:

• Two distinct regions of the macrolide tail were found to tolerate significant substituent variations.
• A specific combination of substituents was identified that significantly enhanced the inhibition of ECM invasion.
• The optimized analogues demonstrated potent inhibition of A549 cell ECM invasion.

Conclusions:

• Simplified macrolide analogues targeting actin polymerization can be developed.
• Structural modifications of the Mycalolide B tail can lead to potent inhibitors of cancer cell invasion.
• These findings pave the way for developing targeted cancer therapies with improved synthesis profiles.